
November 19, 2001
Patients who took Propulsid, Janssen Pharmaceutica's heartburn drug banned in 2000 after it was linked to serious heart problems, are seeking retribution. If the results of the first case against the drug maker are any indication, Propulsid victims will succeed. A Mississippi jury recently awarded ten plaintiffs $100 million in compensatory damages, the first verdict against the Johnson and Johnson subsidiary.
The attorney representing the plaintiffs, one child and ten adults who claimed the drug caused irregular heartbeats and anxiety, argued that the drug maker knew Propulsid caused serious side effects, yet failed to properly warn the public. Attorneys also produced evidence that the company increased its marketing efforts even after realizing that the drug would be banned.
Jurors were presented reports revealing that as early as 1995 the Food and Drug Administration told Janssen that it believed Propulsid caused heart arrhythmia. More than 80 deaths have been attributed to Propulsid over the last eight years.
There are currently over 700 lawsuits pending against the drug maker.
-- Article Courtesy of InjuryBoard.com
.
Contents & Site Design © Injury Issues.com